{'fraction_non_alphanumeric': 0.017150395778364115, 'fraction_numerical': 0.0, 'mean_word_length': 6.160377358490566, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Investigations into the antibacterial activities of phytotherapeutics against Helicobacter pylori and Campylobacter jejuni

The prevalence of gastric diseases is increasing with H. pylori, the causative agent of acute and chronic gastritis, being a major predisposing factor for peptic ulcer disease and gastric carcinoma. C. jejuni is the most common cause of enteric infections, particularly among children, resulting in severe diarrhoea. Increasing drug resistance of these bacteria against standard antibiotics, and the more widespread use of herbal medicines, favours investigations into additional anti‐Helicobacter and anti‐Campylobacter effects of phytotherapeutics that are already used for their beneficial effects on bowel and digestive functions.